financetom
Business
financetom
/
Business
/
Mercator Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing August 14, 2026
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mercator Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing August 14, 2026
Aug 12, 2026 9:33 PM

Norwalk, CT, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Mercator Acquisition Corp. ( MRCOU ) (the “Company”) announced today that, commencing August 14, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq under the symbols “MRCO” and “MRCOW,” respectively. Those units not separated will continue to trade on the Nasdaq under the symbol “MRCOU.”

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Mercator Acquisition Corp. ( MRCOU )

Mercator Acquisition Corp. ( MRCOU ) is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an initial business combination target in any business or industry or at any stage of its corporate evolution. Its primary focus, however, will be in completing a business combination with an established business of scale poised for continued growth, led by a highly regarded management team.

The Company’s management team is led by Shawn Matthews, its Chairman of the Board and Chief Executive Officer, Shawn P. Matthews Jr., its President, and Steven Bischoff, its Chief Financial Officer. The Company’s Board of Directors includes James Nash, Steve Schwartz, and Matthew Sweeney.

Forward-Looking Statements

This press release may include, and oral statements made from time to time by representatives of the Company may include, “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company’s filings with the Securities and Exchange Commission (“SEC”). All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Media Contact:

Steven Bischoff

[email protected] 

Image: https://www.globenewswire.com/newsroom/ti?nf=OTgwOTA5NCM3Nzc0MDExIzUwMDE2NTAxMQ==

Image: https://ml.globenewswire.com/media/YzU1MTE5ZDItNDBhOC00Y2UxLWJjNDAtZTZhYTk1MWYwN2RjLTUwMDE2NTAxMS0yMDI2LTA4LTEyLWVu/tiny/Mercator-Acquisition-Corp-.png

Source: Mercator Acquisition Corp. ( MRCOU )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Clearwater Analytics Completes Acquisition of Risk and Performance Analytics Solutions From Wilshire
Clearwater Analytics Completes Acquisition of Risk and Performance Analytics Solutions From Wilshire
Apr 22, 2024
06:00 PM EDT, 04/22/2024 (MT Newswires) -- Clearwater Analytics ( CWAN ) said Monday it completed the acquisition of risk and performance analytics products from Wilshire Advisors. Wilshire Axiom, Wilshire Atlas, Wilshire Abacus and Wilshire iQComposite will be integrated with Clearwater's offerings. Clearwater previously said the assets will cost $40 million and add about $7 million in annualized revenue. ...
Copper output at Chile's Codelco set to rise this year, CESCO says
Copper output at Chile's Codelco set to rise this year, CESCO says
Apr 22, 2024
SANTIAGO (Reuters) - Chile's state-run copper miner Codelco is poised to improve production this year and begin to climb from its lowest dip in a quarter century, the head of Chilean copper studies center CESCO said ahead of a major industry conference that starts Monday. Codelco is aiming to produce between 1.325 million and 1.390 million metric tons of copper...
U.S. FDA approves ImmunityBio's bladder cancer therapy
U.S. FDA approves ImmunityBio's bladder cancer therapy
Apr 22, 2024
April 22 (Reuters) - The U.S. FDA approved ImmunityBio's ( IBRX ) combination therapy to treat a type of bladder cancer, the regulator said on Monday, which would help bring the company's first product to market. ...
ADM CFO to resign as company faces US government investigation
ADM CFO to resign as company faces US government investigation
Apr 22, 2024
(Reuters) - Grain trader Archer-Daniels-Midland ( ADM ) said on Monday that Chief Financial Officer Vikram Luthar will resign from his role effective Sept. 30. Luthar is the highest-level executive to leave the firm since it disclosed accounting issues within its Nutrition division that later triggered two government investigations and forced it to revise six years of financial data. ADM...
Copyright 2023-2026 - www.financetom.com All Rights Reserved